Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIA study of IRL790 in Parkinson's disease dyskinesia
2017-003458-18Phase 2Completed
- Sponsor
- IRLAB
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mesdopetam in Parkinson's disease (PD), sponsored by IRLAB. Started Sep 2017; status: completed.
02
Drugs
mesdopetam
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2017-003458-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003458-18.